PGEN

#2176
Precigen, Inc. Common Stock
4.06 USD
-2.64%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
4.06
4.16
Year Range
1.22
5.47
Daily Change
-2.64%
Monthly Change
+14.37%
6 month change
+26.09%
Year Change
+187.94%
Previous Close
4.17
Open
4.16
Bid
Ask
Low
4.06
High
4.16
Volume
285
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.44 B
  • Employee 47
  • Founded 1998
  • CEO Helen Sabzevari
  • Website www.precigen.com
  • Headquarter Virginia, United States
  • FIGI BBG000QL8VH9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Precigen Inc

Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

News